Amdahl, J., Diaz, J., Sharma, A., Park, J., Chandiwana, D., & Delea, T. E. (2017). Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom. PLoS One.

Amdahl, Jordan, Jose Diaz, Arati Sharma, Jinhee Park, David Chandiwana, و Thomas E. Delea. "Cost-effectiveness of Pazopanib Versus Sunitinib for Metastatic Renal Cell Carcinoma in the United Kingdom." PLoS One 2017.

Amdahl, Jordan, et al. "Cost-effectiveness of Pazopanib Versus Sunitinib for Metastatic Renal Cell Carcinoma in the United Kingdom." PLoS One 2017.